The bioinformatics-based analysis found that ADAM12 expression was elevated in ccRCC tissues and an in vitro cell-based assay to validate the expression of ADAM12 protein in ccRCC cell lines and renal epithelial cells. This evidence concerns the gene ADAM12 and nonpapillary renal cell carcinoma.